Tauber Zdenek, Cizkova Katerina, Janikova Maria, Jurcikova Jana, Vitkova Katerina, Pavliska Lubomir, Porubova Ludmila, Krauze Agata, Fernandez Carlos, Jaluvka Frantisek, Spackova Iveta, Lochman Ivo, Prochazka Martin, Johnstone Brian H, Prochazka Vaclav
Department of Histology and Embryology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic.
Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019 Jun;163(2):132-140. doi: 10.5507/bp.2018.048. Epub 2018 Sep 7.
The therapeutic potential of adipose-derived stem cell conditioned medium (ASC-CM) was studied in the rabbit model of critical limb ischemia (CLI).
Rabbits received treatment with ASC-CM or placebo. Gastrocnemius muscle tissue was collected 35 days after ischemia induction. Ischemic changes were evaluated in hematoxylin-eosin stained tissues for early (necrotic lesions/granulation tissue) and late (fibrous scars) phases of tissue repair. The expression of proangiogenic miR-126 was also evaluated using in situ hybridization. The levels of cytokines, insulin, and C-peptide were measured in blood.
Early repair phases were observed more often in placebo-treated samples (45.5%) than in ASC-CM-treated ones (22.2%). However, the difference was not statistically significant. We demonstrated a statistically significant positive correlation between the early healing phases in tissue samples and C-peptide levels in peripheral blood. The expression of proangiogenic miR-126 was also shown in a number of structures in all phases of ischemic tissue healing.
Based on our results, we believe that treatment with ASC-CM has the potential to accelerate the healing process in ischemic tissues in the rabbit model of CLI. The whole healing process was accompanied by miR-126 tissue expression. C-peptide could be used to monitor the course of the tissue healing process.
在兔严重肢体缺血(CLI)模型中研究脂肪来源干细胞条件培养基(ASC-CM)的治疗潜力。
兔子接受ASC-CM或安慰剂治疗。缺血诱导35天后收集腓肠肌组织。在苏木精-伊红染色的组织中评估缺血变化,用于组织修复的早期(坏死病变/肉芽组织)和晚期(纤维瘢痕)阶段。还使用原位杂交评估促血管生成miR-126的表达。测量血液中细胞因子、胰岛素和C肽的水平。
与接受ASC-CM治疗的样本(22.2%)相比,接受安慰剂治疗的样本(45.5%)更常观察到早期修复阶段。然而,差异无统计学意义。我们证明组织样本中的早期愈合阶段与外周血中的C肽水平之间存在统计学上显著的正相关。在缺血组织愈合的所有阶段,促血管生成miR-126也在许多结构中表达。
根据我们的结果,我们认为ASC-CM治疗有可能加速兔CLI模型中缺血组织的愈合过程。整个愈合过程伴随着miR-126的组织表达。C肽可用于监测组织愈合过程的进程。